Details for New Drug Application (NDA): 210961
✉ Email this page to a colleague
NDA 210961 describes CHLORZOXAZONE, which is a drug marketed by Acme Labs, Actavis Elizabeth, Aurobindo Pharma Ltd, Barr, Belcher, Corepharma, Dr Reddys Labs Sa, Endo Operations, Glenmark Pharms Ltd, I3 Pharms, Mikart, Novitium Pharma, Ohm Labs, Pioneer Pharms, Rising, Senores Pharms, Strides Pharma, Sun Pharm Industries, Teva Pharms Usa Inc, Upsher Smith Labs, and Watson Labs, and is included in thirty-five NDAs. It is available from twenty-five suppliers. Additional details are available on the CHLORZOXAZONE profile page.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 210961
| Tradename: | CHLORZOXAZONE |
| Applicant: | Senores Pharms |
| Ingredient: | chlorzoxazone |
| Patents: | 0 |
Pharmacology for NDA: 210961
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 210961
Suppliers and Packaging for NDA: 210961
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 210961 | ANDA | Cintex Services, LLC | 24470-940 | 24470-940-10 | 100 TABLET in 1 BOTTLE (24470-940-10) |
| CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 210961 | ANDA | Cintex Services, LLC | 24470-940 | 24470-940-50 | 500 TABLET in 1 BOTTLE (24470-940-50) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Jan 22, 2024 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
